Filing Flows › Corteva (CTVA) › Stock forecast & fair value
Corteva (CTVA) stock forecast and fair value
Corteva (CTVA) trades at $12.04. 13 analysts' median price target is $17.00 (+41%), from $13.65 to $20.00. Across 16 valuation methods the middle fair value is $29.24 (+143%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $23.42 | $32.80 | $55.25 | +172% |
| P/E vs peers, weighted | $29.97 | $40.54 | $49.85 | +237% |
| EV/Sales vs peers | $12.30 | $29.24 | $67.44 | +143% |
| EV/Sales vs peers, weighted | $9.22 | $65.50 | $125.92 | +444% |
| Residual income | $31.67 | $32.89 | $34.18 | +173% |
| Analysts' price targets | $13.65 | $17.13 | $20.00 | +42% |
| Our model (Rotation forecast) | $9.59 | $12.26 | $15.67 | +2% |
| Owner earnings capitalized | $43.15 | $51.40 | $63.55 | +327% |
| Shareholder yield (dividends + buybacks) | $37.97 | $45.23 | $55.92 | +276% |
| Tangible book (asset value) | $8.02 | $10.03 | $10.03 | -17% |
Corteva's latest quarter
Corteva, Q2 2026: revenue $6.4B (-1% year over year), operating margin 24.7%, net earnings $1.2B, operating cash flow −$466M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CTVA stock?
The median of 13 analysts' 12-month targets is $17.00, +41% from $12.04; the range is $13.65 to $20.00. The average rating is buy.
What is Corteva's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $10.03 and $65.50, with a middle value of $29.24 against a price of $12.04. Each method's assumptions are on the page.
Is CTVA stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.